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Abstract:  It has been reported that there is an association between pancreatic cancer and obesity, impaired glucose
metabolism and diabetes based on excess dietary fat and sugar intakes.  A number of studies have suggested that a high-
fat diet increases development of carcinomas in various organs and possible risk factors for pancreatic cancer.  However,
how an excess sugar intake promotes pancreatic carcinogenesis is still unknown.  In the present study, we investigated
the influence of an excess sugar intake on pancreatic carcinogenesis by administration of a sucrose-rich diet in which
starch was replaced by sucrose in order to contain the same calories and other nutrients.  Two similar experiments were
performed.  Six-week-old male Syrian golden hamsters were given N-nitrosobis (2-oxopropyl) amine (BOP) at a dose
of 50 and 20 mg/kg body weight as a carcinogen in Week 0 and 1, respectively.  In Week 2, the animals were divided
into control and experimental groups.  In experiment 1, 15 animals received a control diet or sucrose-rich diet in which
100% of the starch was replaced by sucrose, respectively.  Since five animals fed on the sucrose-rich diet died by Week
12, the diet was changed to a sucrose-rich diet in which 50% of the starch was replaced by sucrose.  In experiment 2,
15 animals received a control diet or sucrose-rich diet in which 50 or 20% of the starch was replaced by sucrose,
respectively.  All animals were sacrificed 25 weeks after the start of the experiment, and histological examination of the
pancreas was performed.  No significant difference was seen in the body weight at the end of the experiment.  There
were no significant differences in the glycosylated hemoglobin (HbA1c) and serum triglyceride, total cholesterol and
HDL-cholesterol levels between the control and sucrose-rich diet groups in experiments 1 and 2.  The incidence and
number of carcinomas increased in hamsters fed the sucrose-rich diet compared with the control diet in experiments 1
and 2.  These results suggest that an excess sucrose intake may promote the development of pancreatic cancer in
hamsters.  (J Toxicol Pathol 2010; 23: 19–24)
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Introduction
Despite recent diagnostic and therapeutic advances,
pancreatic cancer shows the highest mortality among
malignancies, with a 5-year survival rate of <5 %.  Thus,
prevention could play an important role in reducing
pancreatic cancer-related mortality.
The risk factors for pancreatic cancer are not yet well-
established, except for cigarette smoking1.  About 80% of
pancreatic cancer patients show impaired glucose
metabolism, insulin resistance and frank diabetes.  However,
the correlation between type 2 diabetes and development of
pancreatic cancer is still contravertial2–4.  Experimental
studies have reported that induction of peripheral insulin
resistance by the administration of a high-fat diet promotes
the development of pancreatic carcinoma in BOP-treated
hamsters, which closely resemble their human
counterparts5–7.  Some epidemiological studies suggest that a
high-fat diet and obesity, which causes peripheral insulin
resistance, may induce compensatory islet cell proliferation
and promote development of pancreatic cancers.  And the
inhibition of islet cell proliferation by streptozotocin and
improvement of insulin resistance by metformin inhibit the
development of pancreatic cancer in hamsters8–12.
It has been shown that an excess dietary sugar intake
may be associated with a greater risk of pancreatic
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cancer13–15.  Insulin can act as a promoter of tumor
development by inhibiting apoptosis and stimulating cell
proliferation16.  Therefore, impaired glucose metabolism,
insulin resistance and hyperinsulinemia may be risk factors
associated with pancreatic cancer.  Furthermore, slightly
elevated risks of pancreatic cancer, especially those
associated with sucrose, have been obseved in overweight
and obese people who may already have developed insulin
resistance13, 16.  However, few experimental studies have
investigated the effects of dietary sugar intake and impaired
glucose metabolism on pancreatic carcinogenesis.
In the present study, the effect of excess sugar intake on
pancreatic carcinogenesis was investigated using a sucrose-
rich diet, in which starch was replaced at rates of 20, 50 and
100% by sucrose in order to administer the same levels of
calories and the other nutrients, in a hamster-based
experimental model for pancreatic adenocarcinomas.
Materials and Methods
Animals
Five-week-old male Syrian golden hamsters weighing
approximately 90 g were obtained from Japan SLC
(Shizuoka, Japan) and acclimated to the laboratory for one
week.  They were housed three or four per plastic cage in an
air-conditioned room at 24°C and 60% humidity, with a
daily 12-hour alternating cycle of light and dark.  Body
weights were measured weekly, and food consumption was
measured twice a week.
Diets
All feed was obtained from CLEA Japan, Inc. (Osaka,
Japan).  The animals in the control group received a
semipurified diet containing 65% starch (50% corn starch
and 15% α-starch), 20% milk casein, 5.0% soybean oil,
5.0% cellulose, 3.5% mineral mix and 1.0% vitamin mix
(control diet).  The animals in sucrose-rich diet group
received the same semipurified diet except that 20, 50 or
100% of the starch was replaced by sucrose (20S, 50S and
100S diets, respectively).  The compositions of the diets are
shown in Table 1.  All diets provided approximately 3.85
kcal/g of chow, and the animals had free access to food and
water for 25 weeks.
Study design
Two similar experiments were performed according to
the following protocol.  In experiment 1, thirty hamsters at 6
weeks of age were used.  BOP (Nacalai Tesque, Kyoto,
Japan) at a dose of 50 or 20 mg/kg body weight was
administered subcutaneously in Weeks 0 and 1, respectively.
The animals were randomized into two dietary groups of 15
animals each at in Week 2.  They subsequently received a
control or 100S diet.  Since five animals fed on the 100S diet
died by Week 12, the diet was changed to a 50S diet starting
in Week 14.  In experiment 2, forty-five hamsters at 6 weeks
of age were used.  BOP at a dose of 50 or 20 mg/kg body
weight was administered subcutaneously in Weeks 0 and 1,
respectively.  The animals were randomized into three
dietary groups of 15 animals each in Week 2.  They
subsequently received a control, 20S or 50S diet.
In experiments 1 and 2, animals were sacrificed at 25
weeks after the start of the experiment.  Animals were fasted
for at least 15 hours before autopsy.  Blood samples were
collected from the inferior vena cava under pentobarbital
anesthesia.  Serum were stored at –80°C until being assayed
for triglycerides and total and HDL cholesterol, and blood
cell-precipitates were stored at 4°C until assayed for
glycosylated hemoglobin (HbA1c;immunoagglutination
methods by SEKISUI MEDICAL Co., Ltd, Tokyo, Japan).
In experiment 2, serum were assayed for glucose and insulin
(ELISA methods by Shibayagi Co., Ltd, Gunma, Japan) in
addition to the items examined in experiment 1.  At autopsy,
the pancreas, liver and adipose tissue (epididymal fat) were
totally removed and weighed.  The pancreas was fixed in
10% phosphate-buffered formalin (pH 7.4) after spreading
on filter paper, processed for histology by conventional
 Table 1. Composition of Experimental Diets (g/100 g)
Components Control diet Sucrose-rich diet
100S 50S 20S
Corn starch 50 – 25 40
α-starch 15 – 7.5 12
Sucrose – 65 32.5 13
Milk casein 20 20 20 20
S o y b e a n  o i l 5555
C e l l u l o s e 5555
Mineral mix 3.5 3.5 3.5 3.5
V i t a m i n  m i x 1111
L-cystine 0.3 0.3 0.3 0.3
Choline bitartrate 0.25 0.25 0.25 0.25
Butylhydroquinone 0.0014 0.0014 0.0014 0.0014
E n e r g y  ( k c a l / g ) 3 . 8 53 . 8 53 . 8 53 . 8 5
100S: 100% sucrose-rich diet. 50S: 50% sucrose-rich diet. 20S: 20% sucrose-rich diet.Sakamoto, Goya, Degawa et al. 21
methods, and embedded in paraffin wax.  It was then
sectioned and stained with hematoxylin and eosin for
histopathological examination.
All experiments were conducted in accordance with
guidelines for Animal Experiments at Nara Medical
University, which are in line with other guidelines and laws
concerning animal rights.
Statistical analysis
The experimental data, except for the incidence of
lesions, are expressed as the mean ± SD.  Statistical
significance between groups was compared using the
Student’s t-test for mean data and the Fisher’s exact test for
incidence data in experiment 1 and using the Tukey’s HSD
test for mean data and the chi-square test for incidence data
in experiment 2.
Results
Clinical signs and survival
In experiment 1, five animals fed the sucrose-rich diet
lost weight rapidly and died by Week 12.  At autopsy, liver
nodules were observed in the dead animals, but the cause of
death was not clear.  After the diet was changed to a sucrose-
rich diet in which 50% of the starch was replaced by sucrose,
no deaths occurred in the animals during the period of
experiment.
In experiment 2, there ware no adverse clinical signs or
deaths.
Gross findings
In experiments 1 and 2, liver nodules were observed in
all animals at the end of the experiment.
Body weight, relative organ weights and energy intake
In experiment 1, there were no significant differences in
body weight between the control and sucrose-rich diet
groups throughout the experiment period, whereas the
energy intake in the sucrose-rich diet group was lower than
that in the control diet group (21.4 ± 2.8 vs. 23.6 ± 3.5 kcal/
day, P<0.01, respectively).  In experiment 2, there were no
significant differences in body weight between the control,
20S and 50S diet groups throughout the experiment period
(Fig.1), whereas the energy intake in the 50S diet group was
lower than that in the control and 20S diet groups (20.0 ± 3.9
vs. 22.8 ± 5.1 kcal/day, P<0.01 and 20.0 ± 3.9 vs. 22.1 ± 3.3
kcal/day, P<0.05, respectively).  Body weight gain tended to
increase in the 50S group, but there were no statistically
significant differences.  There were no significant
differences in the relative weights of the pancreas, liver and
Fig. 1. Mean body weight changes in hamsters fed sucrose-rich diets.
Table 2. Effects of Sucrose-Rich Diets on the Final Body Weight, Relative Organ Weights and Energy Intake
Experiment 1
Group Effective No. Body weight Pancreas Liver Epididymal fat Energy intake
of animals (g) (%) (%) (%) (kcal/day)
Control 15 144 ± 25 0.58 ± 0.2 4.6 ± 0.5 2.4 ± 0.5 23.6 ± 3.5
100S+50S 10 142 ± 27 0.67 ± 0.2 5.4 ± 2.8 2.4 ± 0.7 21.4 ± 2.8**
Experiment 2
Group Effective No. Body weight Pancreas Liver Epididymal fat Energy intake
of animals (g) (%) (%) (%) (kcal/day)
Control 8 129 ± 21 0.48 ± 1.2 4.4 ± 1.2 1.9 ± 0.3 22.8 ± 5.1
20S 9 153 ± 21 0.70 ± 0.2 4.6 ± 0.8 2.3 ± 0.5 22.1 ± 3.3
50S 11 141 ± 24 0.58 ± 0.1 4.4 ± 0.7 2.3 ± 0.5 20.0 ± 3.9**#
Values are expressed as the mean ± SD. Organ weights are expressed as a percentage of body weight.  **: P<0.01 compared with the control
group.  #: P<0.05 compared with the 20S diet group.22 Promotion Effects of Sucrose-rich Diet on Pancreatic Carcinogenesis in Hamsters
epididymal fat between the control and sucrose-rich diet
groups in both experiments 1 and 2 (Table 2).
Serum glucose, insulin and glycosylated hemoglobin
In experiment 1, there were no significant differences in
the HbA1c levels of both groups.  In experiment 2, there
were no significant differences in the HbA1c and serum
glucose and insulin levels between groups (Table 3).
Serum triglycerides and cholesterol
In experiments 1 and 2, there were no significant
differences in the serum triglyceride, total cholesterol and
HDL-cholesterol levels between groups (Table 3).
Incidence and number of pancreatic adenocarcinomas
In this study, proliferative ductal lesions of the pancreas
were classified into atypical hyperplasia and
adenocarcinoma.  Proliferative ductal lesions were
diagnosed according to well-established criteria that have
been described previously17.  In experiment 1, the incidence
and number of pancreatic adenocarcinomas increased in the
sucrose-rich diet group compared with the control group
(50.0 vs. 6.7% and 0.6 ± 0.7 vs. 0.1 ± 0.3/animal, P<0.05,
respectively).  In experiment 2, the incidence and number of
adenocarcinomas were higher in the 20S diet group
compared with the control and 50S diet groups (44.4 vs. 0
and 18.2%, P<0.05, and 1.0 ± 1.3 vs. 0 and 0.2 ± 0.4/animal,
P<0.05, respectively).  In addition, the incidence of
proliferative ductal lesions including atypical hyperplasia
and adenocarcinoma increased in the 50S groups compared
with the control and 20S diet groups (90.9 vs. 50.0 and
66.7%, P<0.05, respectively; Table 4).
Table 3. Effects of Sucrose-Rich Diets on the Serum Glucose, Insulin, Triglyceride, Cholesterol and Glycosylated Hemoglobin
Levels
Experiment 1
Group Effective No. HbA1c TG T-CHO HDL-C
of animals (%) (mg/dL) (mg/dL) (mg/dL)
Control 15 4.1 ± 3.7 307 ± 84 195 ± 38 44 ± 29
100S+50S 10 4.1 ± 3.9 332 ± 101 196 ± 49 42 ± 25
Experiment 2
Group Effective No. GLU INS HbA1c TG T-CHO HDL-C
of animals (mg/dL) (ng/mL) (%) (mg/dL) (mg/dL) (mg/dL)
Control 8 90 ± 17 7.5 ± 5.5 2.8 ± 0.4 127 ± 54 176 ± 28 107 ± 17
20S 9 105 ± 31 7.7 ± 4.4 3.3 ± 0.9 157 ± 49 185 ± 16 108 ± 24
50S 8 112 ± 22 5.9 ± 5.2 3.4 ± 0.6 179 ± 48 169 ± 25 97 ± 19
Values are expressed as the mean ± SD.  HbA1c: glycosylated hemoglobin. TG: triglycerides. T-CHO: total cholesterol. HDL-C:
high-density lipoprotein cholesterol. GLU: glucose. INS: insulin.
Table 4. Effects of Sucrose-Rich Diets on the Number and Incidence of BOP-Induced Pancreatic Lesions in Hamsters
Experiment 1
Group Effective No. AH AC
of animals
Control 15 0.6 ± 0.7 0.1 ± 0.3 (6.7)
100S+50S 10 1.2 ± 0.8 0.6 ± 0.7* (50.0*)
Experiment 2
Group Effective No. AH AC AH + AC
of animals
Control 8 0.6 ± 0.7 0 (0) 0.6 ± 0.7 (50.0)
20S 9 1.4 ± 1.7 1.0 ± 1.3# (44.4#)2 . 4 ± 2.7 (66.7)
50S 11 1.3 ± 1.1 0.2 ± 0.4 (18.2) 1.5 ± 0.9 (90.9#)
AH: atypical hyperplasia. AC: adenocarcinoma.  The number of lesions is expressed as the mean ± SD, and the
incidence (%) of lesion is shown in parentheses.  *: P<0.05 compared with the control group.  #: P<0.05 compared with
the other groups.Sakamoto, Goya, Degawa et al. 23
Other pancreatic lesions were not observed in ether
experiment.
Discussion
Our present study demonstrated that a sucrose-rich diet
in which starch was replaced by sucrose promoted BOP-
induced pancreatic carcinogenesis in hamsters for 25 weeks,
but did not induce hyperglycemia, hyperinsulinemia or
hyperlipidemia.  Under the experimental conditions
employed in this study, there were no marked differences in
the total calorie, lipid, protein or vitamin intakes among the
groups, suggesting that excessive sucrose consumption
promotes pancreatic carcinogenesis.  In experiment 1, some
animals in the 100S diet group died.  However, the causes of
death were unclear.  In experiment 2, the pancreatic
carcinogenesis-promoting effects of the 50S diet were less
marked than those of the 20S diet.  This was possibly
because some other influence for promoter effect appeared
when starch was replaced by sucrose at 50% or more.
Epidemiological studies have reported that high
fructose and sucrose intakes are associated with a greater
risk of pancreatic cancer13–15.  A high intake of fructose and
sucrose has a strong association with overweight and obesity
in human and experimental animals18–21.  In experiment 2,
although the energy intake in the 50% sucrose-rich diet
group was significantly lower than that in the control group,
body weight gain tended to increase.  The PFC rates indicate
the percentages of calorie intake derived from protein (P), fat
(F) and carbohydrates (C) of the total dietary calorie intake.
Nutritionally, a P rate of 12 to 13%, F rate of 20 to 30%, and
C rate of 57 to 68% are considered appropriate.  The PFC
rates of standard Japanese food are approximately 13, 29 and
58%, respectively, similar to the optimal rates.
Internationally, dietary starch energy intake decreases with
an increase in the national income, and animal protein, fat
and sugar consumption increases.  In the average Japanese
diet, appropriate PFC ratios are still maintained.  However,
currently, fat and sugar intake has slightly increased in
comparison with the period from 1955 to 196422.  The PFC
rates of the 20S diet employed in this experiment were 20.8,
11.7 and 67.5% (sucrose: 13.5%), respectively.
Extrapolation of this diet to human diet (2,000 kcal per day)
shows that the calorie intake from sucrose is 270 kcal.  This
value corresponds to 67.5 g of sucrose, similar to the amount
of sugar contained in approximately 500 ml of a soft drink.
The results of this experiment support the fact that frequent
consumption of favorite foods such as soft drinks, breads,
cakes, ice cream and jam in daily life is a risk factor for
pancreatic cancer.
These results indicate that, even when the calorie intake
from carbohydrates is similar, an increase in calorie intake
from sucrose, in comparison with that from starch, promotes
the development of pancreatic cancer.  Sucrose is more
rapidly absorbed compared with starch, increasing the blood
sugar level earlier.  Therefore, the blood level of insulin is
elevated.  As a growth factor, insulin stimulates pancreatic
cancer cell proliferation.  The sucrose-rich diets may have
promoted pancreatic carcinogenesis by transiently
increasing the blood insulin level more markedly in
comparison with the starch diet.  In this experiment, there
were no significant differences in the insulin level among the
groups.  However, this was possibly because the insulin level
was measured after fasting.  The relationship of the rate and
duration of the postprandial increase in the insulin level with
pancreatic carcinogenesis should be further investigated.  On
administration of 10% sucrose in the drinking water to
hamsters for up to 24 weeks, the blood glucose levels of the
hamsters remained within the normal range, while those of
the rats did not23–25.  The hamsters remained normoglycemic
as a result of a neogenetic reaction of islet β-cells, while rats
lack such a neogenetic reaction.  In humans,
hyperinsulinemia is observed in the initial phase of type 2
diabetes.  However, when the condition persists, β cells are
affected, reducing insulin secretion.  Epidemiologically, the
correlation between type 2 diabetes and pancreatic cancer
development is still obscure.  This may be because patients
showing various insulin levels were enrolled in previous
studies.
In conclusion, the sucrose-rich diets promoted
pancreatic carcinogenesis without inducing obesity, diabetes
or hyperlipidemia in hamsters.  Sucrose at the level
contained in the 20S diet can also be realistically ingested by
humans, suggesting that the daily consumption of a large
amount of sugar is a risk factor for pancreatic cancer.
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